Sterling Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-810
Closed -$285K 117
2026
Q1
$285K Hold
810
0.08% 89
2025
Q4
$265K Hold
810
0.08% 91
2025
Q3
$229K Hold
810
0.07% 96
2025
Q2
$226K Buy
+810
New +$229K 0.08% 100
2024
Q4
$209K Sell
803
-31
-4% -$9.2K 0.08% 103
2024
Q3
$269K Buy
834
+31
+4% +$10.1K 0.1% 95
2024
Q2
$251K Hold
803
0.12% 90
2024
Q1
$228K Sell
803
-20
-2% -$5.85K 0.11% 91
2023
Q4
$237K Buy
+823
New +$224K 0.13% 82

Other funds holding AMGN

Sterling Wealth Management's AMGN Position: Q2 2026 in Review

Sterling Wealth Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 810 shares — an estimated $285K sold.

Sterling Wealth Management first reported a position in AMGN in Q4 2023 and held it in 9 quarters. The position peaked at $285K in Q1 2026. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sterling Wealth Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Sterling Wealth Management sold 810 Amgen shares in Q2 2026, an estimated $285K.
  • Sterling Wealth Management first reported a position in Amgen in Q4 2023 and held it in 9 quarters.
  • Sterling Wealth Management's Amgen position peaked at $285K in Q1 2026.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sterling Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.